The independent source for health policy research, polling, and news.
6,541 - 6,560 of 15,449 Results
Californians and Americans are living longer with cancer — but some are living longer than others. California Healthline’s Facebook Live addresses disparities in cancer diagnosis, treatment and care — and what can be done about them.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The measure, which will appear on the November ballot, seeks to cap industry profits. The SEIU-UHW union has raised almost $17 million, but opponents from the industry have invested more than four times that.
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
Reflections on coping with a new high-stress profession.
In the bipartisan opioid bill headed to the president’s desk, hospice workers would be allowed to destroy patients’ unneeded opioids, reducing the risk that families misuse them.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.
Older adults who lack a conventional support system should plan ahead to deal with life’s predictable challenges as they age.
Once viewed as a promising cost-control tool, such insurance faces new competition on benefits menus from more traditional insurance. But, according to new research, none of those choices is getting less expensive.
A project that started in a Boston Veterans Affairs facility will soon go nationwide. It puts naloxone, also known as Narcan, into emergency supplies cabinets throughout the VA system.
Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there’s a twist involving an opioid treatment.
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
Immigrants accounted for nearly 13 percent of premiums paid to private plans but only about 9 percent of insurers’ expenditures, according to a new study in Health Affairs. The cost of care for the group of native-born customers, however, exceeded their premiums.
Students from eight medical schools in and around New York City attended a conference Sept. 23 on progressive activism during their training years — and beyond.
In a Medicaid-funded pilot project starting with 19 counties, clinicians and other providers are now in charge of deciding what kind of treatment an offender needs. The change has rankled some judges and attorneys — and forced some felons to spend more time in jail — but it has been largely embraced by clinicians and county agencies.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Ollstein of Politico talk about how health issues will play in midterm elections, the Trump administration’s move that could penalize legal immigrants who use government aid programs, and other topics. Due to technical difficulties, the original discussion taped Sept. 27 at the 2018 Texas Tribune Festival could not be broadcast, so the panelists reconvened from Austin and Washington on Sept. 28.
State legalization efforts, as well as the introduction of edible or vaporized cannabis- infused products, may be contributing to experimentation by teens.
Federal family planning funds, known as Title X, will soon fund for-profit women’s clinics that bar condoms, hormonal birth control and IUDs and offer only “natural family planning.”
The protection is a win for people who get their needed, legitimate drugs from overseas.
© 2026 KFF